Skip to main content

Article

Ebola 2026: Employer Advisory – Workforce health and travel risk briefing

WHO declares Ebola outbreak a public health emergency. This article covers key employer operational and workforce considerations.

The situation at a glance

On May 17, 2026, the World Health Organization (WHO) declared the Ebola virus disease outbreak caused by the Bundibugyo virus in the DRC and Uganda a Public Health Emergency of International Concern (PHEIC). This is the organization’s highest alert designation, reserved for events with demonstrated cross-border potential requiring coordinated international action.

As of May 26, 2026, more than 1,200 suspected or confirmed cases — and 238 suspected plus 18 confirmed deaths — have been reported. However, experts note the true number of infections is likely considerably higher than the confirmed case count. The outbreak is no longer confined to a single province: confirmed cases span Ituri, Nord-Kivu, and Sud-Kivu provinces in the DRC, and several (seven as of 26 May) cases linked to the DRC outbreak have been reported in Uganda.

What distinguishes this outbreak from prior DRC Ebola events is the strain involved. The two licensed Ebola vaccines and both monoclonal antibody treatments target the Zaire ebolavirus strain and have no established cross-protection against the Bundibugyo virus. The response is relying entirely on classical containment measures: case isolation, contact tracing, and safe burials. It has been hamstrung by conflict and ongoing population displacement in the region.

What the WHO and international health authorities are saying

The WHO currently assesses the overall public health risk of the Bundibugyo virus disease as very high at the national level in DRC and Uganda, high at the regional level, and low at the global level. However, it has cited evidence of undetected transmission ongoing for several weeks before laboratory confirmation. National health authorities across multiple regions have now activated their response systems:

Africa

Africa CDC has assumed a central coordinating role in response to the Ebola outbreaks in the DRC and Uganda, citing the risk of regional spread from cross-border movement and insecurity. The WHO and Africa CDC have activated a continental Incident Management Support Team to coordinate surveillance, laboratory systems, case management, infection prevention, and risk communication. Africa CDC is also escalating engagement with the African Union and WHO for continent-wide emergency action, prioritizing investment in outbreak control capacity, including diagnostics, frontline response, and medical countermeasure development.

Americas

The Pan American Health Organization (PAHO) has advised countries across the Americas to strengthen preparedness following the WHO’s emergency declaration, while stating that the risk to the general population in the region remains low. PAHO has called for reinforced surveillance, laboratory readiness, infection prevention and control measures, and health system preparedness.

UK

The UK Health Security Agency (UKHSA) has confirmed that the current outbreak poses a low risk to the UK population, while noting that the NHS has in place safe procedures and specialist centers for any returning cases. Critically for employers, UKHSA has activated the Returning Workers Scheme, which aims to protect and monitor the health of individuals traveling from the UK to affected areas for their work. Organizations deploying workers to affected areas where they may be exposed to Ebola should register those workers with the scheme. The Foreign, Commonwealth & Development Office (FCDO) continues to update travel advisories.

European Union

The European Centre for Disease Prevention and Control continues to monitor the situation. It said that the overall risk for the general population in Europe is currently very low and advises seeking medical care promptly if symptoms develop within 21 days of return, and of informing healthcare providers about travel history and possible exposure.

Presumed timelines

Employers should plan conservatively. Previous Bundibugyo outbreaks in 2007 and 2012 lasted approximately 97 to 106 days and were contained entirely through standard public health interventions—such as contact tracing and strict isolation—as there are no approved vaccines or targeted therapies for the Bundibugyo strain. The current outbreak presents compounding factors: geographic spread across multiple provinces and an international capital (Kampala), no available vaccine or treatment, active humanitarian conflict in the affected region, and a four-week detection lag that allowed undetected community transmission before the international response was triggered. Organizations should build scenario plans assuming active travel restrictions and border disruptions persist through at least the third quarter of 2026.

The employer imperative: Stranded travelers and border restrictions

The most immediate operational challenge for multinational employers is the risk of employees becoming stranded. Multiple governments have moved swiftly to restrict entry from affected countries. Unless an employee is a citizen of a country that has not imposed restrictions, they may be refused entry if they have been in the DRC in the preceding 21 to 30 days. This applies even to transit passengers on certain routes. The 21-day incubation monitoring window means that employees who have recently departed the region retain an ongoing monitoring obligation that follows them across borders.

UK-based organizations deploying individuals to affected areas where they might be directly exposed to Ebola (for example, humanitarian and healthcare organizations) should register with UKHSA's Returning Workers Scheme and regularly monitor government updates.

Key considerations for employers

  1. Reactivate your pandemic or health security committee: If your pandemic governance structure went dormant post-COVID, you should convene it immediately. The committee should span HR, legal, risk, security, and occupational health. Its immediate mandate: assess current employee exposure, review travel schedules to the affected region and adjacent countries, and establish a clear escalation protocol.
  2. Engage your travel risk management provider: International SOS, Crisis24Horizon, Healix, and similar providers are issuing real-time, country-specific Ebola advisories. Their medical evacuation networks are critical for employees stranded or symptomatic in affected regions. The first known Ebola medical evacuation to Europe in the current outbreak took place on May 19, 2026, when an affected individual was airlifted to Berlin's Charité hospital — a reminder that medical evacuation is a live operational reality, not a theoretical contingency.
  3. Comply with national government travel advisories — and document your actions: Employers have a duty of care to traveling employees. Multiple governments have now issued advisories ranging from “reconsider non-essential travel” to outright travel bans for the DRC, Uganda, and South Sudan. Employers who send staff against active government advice risk both employee harm and legal and insurance exposure. Although this varies by jurisdiction and insurer, commercial travel insurance may include limiting provisions and/or exclusions in coverage if the journey proceeds against government advice. Employers should therefore document the rationale for any essential trip and confirm that the insurer has agreed to waive any such restrictions.
  4. Implement a 21-day return monitoring protocol: Any employee returning from the DRC, Uganda, or other adjacent countries must follow a structured 21-day health monitoring protocol. Employees must be able to report symptoms without stigma or financial penalty — paid leave provisions for monitoring periods are both ethically appropriate and operationally essential. Self-isolation and prompt escalation to a clinician or local health authority should be clearly communicated as the default.
  5. Register in-region workers with your national scheme: For example, UK employers should register relevant staff with the UKHSA Returning Workers Scheme. Enrolment in these schemes ensures coordinated monitoring and reduces the risk of employees navigating a health incident in isolation.
  6. Brief managers on recognition and escalation: Line managers are the first line of detection for returning employees. A brief, factual communication on symptom recognition (fever, vomiting, diarrhea, or unexplained bleeding within 21 days of travel) and escalation pathways reduces panic and enables rapid response.
  7. Review business continuity for in-region operations: Organizations with supply chains, extractive industry, NGOs, or logistics operations in eastern DRC should assess their exposure now. The outbreak is actively spreading across provinces in a densely connected trade corridor. Review force majeure provisions, engage in-country partners, and identify operational alternatives in case primary access is disrupted.

The bottom line

This is a rapidly evolving, high-consequence event with no available vaccine. Governments from London to Canberra, Ottawa to Abu Dhabi, are aligning on the same core message: avoid travel to the affected region (some specify non-essential), monitor returning workers rigorously, and comply with national advisory frameworks. The employers who will navigate this well are those who treat it as an active operational and duty-of-care matter, not as background news.


This document was written in May 2026, based on publicly available information from government, media, and other sources. Conditions are changing quickly and the information may become out of date.

Sources include: World Health Organization (WHO); Africa CDC; UK Health Security Agency (UKHSA); European Centre for Disease Prevention and Control; Johns Hopkins Bloomberg School of Public Health.

 

Speak with a health professional